Skip to main content
Equibles

Creative Planning

Position in CGTX — Cognition Therapeutics Inc

CIK 1540235 OVERLAND PARK, KS
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$25,530
+$2,575 QoQ
Shares Held
22,200
-26.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 66 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. CGTX ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in CGTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,530 22,200
2026-03-31 $22,955 30,204
2025-12-31 $40,505 30,004
2025-09-30 $40,505 30,004
2025-06-30 $6,821 22,004
2025-03-31 $4,211 10,004